Source: AgFunder Thoughts: Glycosylation, once a niche concern in pharma, is quickly becoming a performance frontier in food
It was found that the change in platelet count could be partially explained (adjusted R 2 = 0.41, p = 0.02), with the major factors being Tl (p = 0.002), As (p = 0.01), Cd (p = 0.03), and change in glutathione (p = 0.04)
For clinicians, the practical implication is this: taking a biohacking history is now a clinical necessity
But this doesnt necessarily mean the end of the GLP-1 business for Hims which may continue prescribing the drugs, shortage or not
Zepbound is a registered trademark of Eli Lilly and Company
Here is a plain-English breakdown of the four units that show up on a vial, in a protocol, and on a syringe